Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4059326rdf:typepubmed:Citationlld:pubmed
pubmed-article:4059326lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:4059326lifeskim:mentionsumls-concept:C1522564lld:lifeskim
pubmed-article:4059326lifeskim:mentionsumls-concept:C0030946lld:lifeskim
pubmed-article:4059326lifeskim:mentionsumls-concept:C0151814lld:lifeskim
pubmed-article:4059326lifeskim:mentionsumls-concept:C0728725lld:lifeskim
pubmed-article:4059326lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:4059326lifeskim:mentionsumls-concept:C0205216lld:lifeskim
pubmed-article:4059326lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:4059326lifeskim:mentionsumls-concept:C0068469lld:lifeskim
pubmed-article:4059326pubmed:issue4lld:pubmed
pubmed-article:4059326pubmed:dateCreated1985-12-18lld:pubmed
pubmed-article:4059326pubmed:abstractTextDuring myocardial ischemia in dogs effects of NCO-700, a protease inhibitor on myocardial pH, were investigated. Ischemia was produced for 90 min by partial occlusion of the left anterior descending coronary artery (LAD). Myocardial pH was measured by a micro glass pH electrode inserted in the subendocardium of the LAD area. Before partial occlusion, myocardial pH was 7.50-7.67. It decreased by 0.65 to 0.86 pH units after partial occlusion. NCO-700 was injected intravenously after 30 min partial occlusion. At a dose of 5 or 20 mg/kg NCO-700 increased myocardial pH, which had been decreased by LAD partial occlusion, by 0.26 or 0.31 pH units, respectively. In the nonischemic myocardium pH increased only 0.03 units. Drug-induced restoration of myocardial [H+] was then calculated. At a dose of 5 or 20 mg/kg NCO-700 restored myocardial [H+], which had been increased by partial occlusion. However, NCO-700 did not attenuate the ischemia-induced elevation of ST segment of the surface electrocardiogram. These observations demonstrate that NCO-700 attenuates myocardial pH depressed by partial occlusion of LAD.lld:pubmed
pubmed-article:4059326pubmed:languageenglld:pubmed
pubmed-article:4059326pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4059326pubmed:citationSubsetIMlld:pubmed
pubmed-article:4059326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4059326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4059326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4059326pubmed:statusMEDLINElld:pubmed
pubmed-article:4059326pubmed:issn0031-7012lld:pubmed
pubmed-article:4059326pubmed:authorpubmed-author:HaraAAlld:pubmed
pubmed-article:4059326pubmed:authorpubmed-author:AbikoYYlld:pubmed
pubmed-article:4059326pubmed:authorpubmed-author:IshibashiTTlld:pubmed
pubmed-article:4059326pubmed:authorpubmed-author:HageJJlld:pubmed
pubmed-article:4059326pubmed:issnTypePrintlld:pubmed
pubmed-article:4059326pubmed:volume31lld:pubmed
pubmed-article:4059326pubmed:ownerNLMlld:pubmed
pubmed-article:4059326pubmed:authorsCompleteYlld:pubmed
pubmed-article:4059326pubmed:pagination208-17lld:pubmed
pubmed-article:4059326pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:meshHeadingpubmed-meshheading:4059326-...lld:pubmed
pubmed-article:4059326pubmed:year1985lld:pubmed
pubmed-article:4059326pubmed:articleTitleEffect of NCO-700, an inhibitor of protease, on myocardial pH decreased by coronary occlusion in dogs.lld:pubmed
pubmed-article:4059326pubmed:publicationTypeJournal Articlelld:pubmed